Caption Management, LLC Biotechnology

Caption Management, LLC

  • $9.79 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
CORT
Corcept Therapeutics Inc
PUT
$70.1 Million
613K
Q1 2024
New holding
ARGX
Argenx Se
CALL
$66.9 Million
113K
Q2 2024
New holding
KRYS
Krystal Biotech, Inc.
CALL
$40 Million
222K
Q4 2024
New holding
NVO
Novo Nordisk A S
PUT
$23.9 Million
344K
Q4 2024
Added 659.61%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$19.9 Million
160K
Q2 2022
Closed
ACLX
Arcellx, Inc.
CALL
$18.1 Million
276K
Q1 2025
New holding
VRTX
Vertex Pharmaceuticals Inc
CALL
$14.5 Million
30K
Q1 2024
New holding
EWTX
Edgewise Therapeutics, Inc.
CALL
$14.3 Million
650K
Q1 2025
New holding
PTGX
Protagonist Therapeutics, Inc
CALL
$14 Million
289K
Q4 2024
Added 347.67%
UTHR
United Therapeutics Corp
CALL
$13.9 Million
45K
Q1 2025
New holding
EWTX
Edgewise Therapeutics, Inc.
PUT
$12.8 Million
580K
Q1 2025
New holding
SWTX
Spring Works Therapeutics, Inc.
CALL
$12.3 Million
279K
Q1 2025
New holding
CORT
Corcept Therapeutics Inc
CALL
$12.2 Million
107K
Q1 2024
New holding
MRUS
Merus N.V.
CALL
$11.4 Million
270K
Q4 2024
New holding
INSM
Insmed Inc
PUT
$11.3 Million
148K
Q4 2024
Added 253.23%
SRRK
Scholar Rock Holding Corp
CALL
$10.9 Million
338K
Q1 2025
Reduced 78.11%
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$10.8 Million
297K
Q1 2025
Added 52.1%
BBIO
Bridge Bio Pharma, Inc.
PUT
$10.3 Million
297K
Q4 2024
Reduced 63.5%
EXEL
Exelixis, Inc.
CALL
$10 Million
271K
Q3 2024
Added 122.43%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$9.99 Million
37K
Q3 2024
Reduced 95.07%
PTGX
Protagonist Therapeutics, Inc
PUT
$9.38 Million
194K
Q4 2024
Added 347.67%
XENE
Xenon Pharmaceuticals Inc.
CALL
$8.61 Million
257K
Q3 2023
New holding
BBIO
Bridge Bio Pharma, Inc.
CALL
$8.52 Million
247K
Q4 2024
Reduced 63.5%
ACLX
Arcellx, Inc.
PUT
$7.95 Million
121K
Q1 2025
New holding
RNA
Avidity Biosciences, Inc.
PUT
$7.14 Million
242K
Q4 2024
New holding
TRVI
Trevi Therapeutics, Inc.
CALL
$7.07 Million
1.12M N/A
VKTX
Viking Therapeutics, Inc.
CALL
$7.06 Million
292K
Q4 2024
Reduced 49.49%
ADMA
Adma Biologics, Inc.
CALL
$6.88 Million
347K N/A
SWTX
Spring Works Therapeutics, Inc.
PUT
$6.63 Million
150K
Q1 2025
New holding
IMVT
Immunovant, Inc.
PUT
$6.24 Million
227K
Q4 2024
Reduced 29.3%
ARVN
Arvinas, Inc.
CALL
$6.19 Million
882K
Q1 2025
Reduced 69.21%
AXSM
Axsome Therapeutics, Inc.
CALL
$6.09 Million
52.2K
Q4 2024
Added 1056.86%
GMAB
Genmab A/S
PUT
$5.92 Million
302K
Q1 2025
New holding
ARGX
Argenx Se
PUT
$5.62 Million
9.5K
Q2 2024
New holding
MLTX
Moon Lake Immunotherapeutics
CALL
$5.42 Million
139K
Q4 2024
New holding
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$5.19 Million
450K
Q4 2023
Added 29.04%
IMNM
Immunome Inc.
PUT
$5.05 Million
750K
Q1 2025
New holding
CRNX
Crinetics Pharmaceuticals, Inc.
PUT
$5.03 Million
150K
Q1 2025
New holding
CRSP
Crispr Therapeutics Ag
CALL
$4.89 Million
144K
Q1 2025
Reduced 86.76%
VRNA
Verona Pharma PLC
CALL
$4.69 Million
73.9K
Q3 2024
New holding
ASND
Ascendis Pharma A/S
PUT
$4.68 Million
30K
Q1 2025
Reduced 42.71%
GMAB
Genmab A/S
CALL
$4.1 Million
209K
Q1 2025
New holding
KROS
Keros Therapeutics, Inc.
PUT
$4 Million
393K
Q1 2025
Added 74.81%
INSM
Insmed Inc
CALL
$3.99 Million
52.3K
Q4 2024
Added 253.23%
RPRX
Royalty Pharma PLC
CALL
$3.77 Million
121K N/A
KRYS
Krystal Biotech, Inc.
PUT
$3.61 Million
20K
Q4 2024
New holding
TGTX
Tg Therapeutics, Inc.
PUT
$3.58 Million
90.7K
Q3 2023
New holding
BGNE
Bei Gene, Ltd.
PUT
$3.4 Million
15K
Q4 2022
Added 144.64%
BGNE
Bei Gene, Ltd.
CALL
$3.4 Million
15K
Q4 2022
Added 144.64%
Filter Shares Options
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email